{"id":5645,"date":"2025-09-07T18:11:47","date_gmt":"2025-09-07T18:11:47","guid":{"rendered":"https:\/\/dev.sunpharma.com\/usa\/?page_id=5645"},"modified":"2025-09-07T18:58:06","modified_gmt":"2025-09-07T18:58:06","slug":"media","status":"publish","type":"page","link":"https:\/\/dev.sunpharma.com\/usa\/media\/","title":{"rendered":"Media"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"5645\" class=\"elementor elementor-5645\">\n\t\t\t\t<div class=\"elementor-element elementor-element-619653d elementor-hidden-desktop elementor-hidden-tablet e-flex e-con-boxed e-con e-parent\" data-id=\"619653d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-822402f elementor-widget elementor-widget-image\" data-id=\"822402f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1440\" height=\"712\" src=\"https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero.png\" class=\"attachment-full size-full wp-image-5649\" alt=\"\" srcset=\"https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero.png 1440w, https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero-300x148.png 300w, https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero-1024x506.png 1024w, https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero-768x380.png 768w\" sizes=\"(max-width: 1440px) 100vw, 1440px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6e12b09 e-con-full e-flex e-con e-parent\" data-id=\"6e12b09\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t<div class=\"elementor-element elementor-element-16d365d e-con-full hero-left e-flex e-con e-child\" data-id=\"16d365d\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-974e53d elementor-widget elementor-widget-heading\" data-id=\"974e53d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Media<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-847f0ba e-flex e-con-boxed e-con e-parent\" data-id=\"847f0ba\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7ca07d4 elementor-widget elementor-widget-heading\" data-id=\"7ca07d4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Press Releases<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-111fad2 e-n-tabs-none elementor-widget elementor-widget-n-tabs\" data-id=\"111fad2\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;tabs_justify_horizontal&quot;:&quot;stretch&quot;,&quot;tabs_justify_horizontal_mobile&quot;:&quot;center&quot;,&quot;horizontal_scroll&quot;:&quot;enable&quot;,&quot;horizontal_scroll_tablet&quot;:&quot;enable&quot;,&quot;horizontal_scroll_mobile&quot;:&quot;enable&quot;}\" data-widget_type=\"nested-tabs.default\">\n\t\t\t\t\t\t\t<div class=\"e-n-tabs\" data-widget-number=\"17955538\" aria-label=\"Tabs. Open items with Enter or Space, close with Escape and navigate using the Arrow keys.\">\n\t\t\t<div class=\"e-n-tabs-heading\" role=\"tablist\">\n\t\t\t\t\t<button id=\"e-n-tab-title-179555381\" data-tab-title-id=\"e-n-tab-title-179555381\" class=\"e-n-tab-title\" aria-selected=\"true\" data-tab-index=\"1\" role=\"tab\" tabindex=\"0\" aria-controls=\"e-n-tab-content-179555381\" style=\"--n-tabs-title-order: 1;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\t2025\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-179555382\" data-tab-title-id=\"e-n-tab-title-179555382\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"2\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-179555382\" style=\"--n-tabs-title-order: 2;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\t2024\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-179555383\" data-tab-title-id=\"e-n-tab-title-179555383\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"3\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-179555383\" style=\"--n-tabs-title-order: 3;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\t2023\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-179555384\" data-tab-title-id=\"e-n-tab-title-179555384\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"4\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-179555384\" style=\"--n-tabs-title-order: 4;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\t2022\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-179555385\" data-tab-title-id=\"e-n-tab-title-179555385\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"5\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-179555385\" style=\"--n-tabs-title-order: 5;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\t2021\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-179555386\" data-tab-title-id=\"e-n-tab-title-179555386\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"6\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-179555386\" style=\"--n-tabs-title-order: 6;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\t2020\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-179555387\" data-tab-title-id=\"e-n-tab-title-179555387\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"7\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-179555387\" style=\"--n-tabs-title-order: 7;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\t2019\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t\t<\/div>\n\t\t\t<div class=\"e-n-tabs-content\">\n\t\t\t\t<div id=\"e-n-tab-content-179555381\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-179555381\" data-tab-index=\"1\" style=\"--n-tabs-title-order: 1;\" class=\"e-active elementor-element elementor-element-0c699d3 e-con-full e-flex e-con e-child\" data-id=\"0c699d3\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-65f933f elementor-widget elementor-widget-html\" data-id=\"65f933f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t\n<table id=\"tablepress-14\" class=\"tablepress tablepress-id-14\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Press Releases<\/th><th class=\"column-2\">Date<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-LEQSELVI-at-2024-Fall-Clinical-Dermatology-Conference.pdf\">Sun Pharma Presents LEQSELVI at the 2024 Fall Clinical Dermatology Conference,<\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-WINLEVI-at-44th-Annual-Fall-Clinical-Dermatology-Conference.pdf\">WINLEVI poster presentations at 2024 Fall Clinical Dermatology Conference, <\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/07\/Sunpharma-LEQSELVI-Approval-Scenario-Press-Release.pdf\">U.S. FDA Approves LEQSELVI&trade;(deuruxolitinib), and Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata<\/a><\/td><td class=\"column-2\">July 26, 2024<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-Completes-Taro-Merger.pdf\">Sun Pharma Completes Taro Merger, <\/a><\/td><td class=\"column-2\">June 24, 2024<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-presented-GL0034-phase-1-result-at-the-84th-ADA.pdf\">Sun Pharma&rsquo;s GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions, <\/a><\/td><td class=\"column-2\">June 22, 2024<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Results-of-the-Phase-III-PIVOTAL-trial-of-Nidlegy-in-melanoma-to-be-presented-at-ASCO-2024.pdf\">Press Release Results of the Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024<\/a><\/td><td class=\"column-2\">May 31, 2024<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Taro-Shareholders-Approve-Merger-with-Sun-Pharma.pdf\">Taro Shareholders Approve Merger with Sun Pharma<\/a><\/td><td class=\"column-2\">May 23, 2024<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/01\/1-17-24-Sun-Taro-Joint-Press-Release-Final-for-Release-with-BoA-changes.pdf\">Taro Announces Merger Agreement with Sun Pharma,<\/a><\/td><td class=\"column-2\">January 18, 2024<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-14 from cache -->\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-179555382\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-179555382\" data-tab-index=\"2\" style=\"--n-tabs-title-order: 2;\" class=\" elementor-element elementor-element-ffe3216 e-con-full e-flex e-con e-child\" data-id=\"ffe3216\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9d86afd elementor-widget elementor-widget-html\" data-id=\"9d86afd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t\n<table id=\"tablepress-14-no-2\" class=\"tablepress tablepress-id-14\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Press Releases<\/th><th class=\"column-2\">Date<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-LEQSELVI-at-2024-Fall-Clinical-Dermatology-Conference.pdf\">Sun Pharma Presents LEQSELVI at the 2024 Fall Clinical Dermatology Conference,<\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-WINLEVI-at-44th-Annual-Fall-Clinical-Dermatology-Conference.pdf\">WINLEVI poster presentations at 2024 Fall Clinical Dermatology Conference, <\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/07\/Sunpharma-LEQSELVI-Approval-Scenario-Press-Release.pdf\">U.S. FDA Approves LEQSELVI&trade;(deuruxolitinib), and Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata<\/a><\/td><td class=\"column-2\">July 26, 2024<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-Completes-Taro-Merger.pdf\">Sun Pharma Completes Taro Merger, <\/a><\/td><td class=\"column-2\">June 24, 2024<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-presented-GL0034-phase-1-result-at-the-84th-ADA.pdf\">Sun Pharma&rsquo;s GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions, <\/a><\/td><td class=\"column-2\">June 22, 2024<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Results-of-the-Phase-III-PIVOTAL-trial-of-Nidlegy-in-melanoma-to-be-presented-at-ASCO-2024.pdf\">Press Release Results of the Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024<\/a><\/td><td class=\"column-2\">May 31, 2024<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Taro-Shareholders-Approve-Merger-with-Sun-Pharma.pdf\">Taro Shareholders Approve Merger with Sun Pharma<\/a><\/td><td class=\"column-2\">May 23, 2024<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/01\/1-17-24-Sun-Taro-Joint-Press-Release-Final-for-Release-with-BoA-changes.pdf\">Taro Announces Merger Agreement with Sun Pharma,<\/a><\/td><td class=\"column-2\">January 18, 2024<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-14-no-2 from cache -->\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-179555383\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-179555383\" data-tab-index=\"3\" style=\"--n-tabs-title-order: 3;\" class=\" elementor-element elementor-element-ddc006e e-con-full e-flex e-con e-child\" data-id=\"ddc006e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-be318d6 elementor-widget elementor-widget-html\" data-id=\"be318d6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t\n<table id=\"tablepress-14-no-3\" class=\"tablepress tablepress-id-14\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Press Releases<\/th><th class=\"column-2\">Date<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-LEQSELVI-at-2024-Fall-Clinical-Dermatology-Conference.pdf\">Sun Pharma Presents LEQSELVI at the 2024 Fall Clinical Dermatology Conference,<\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-WINLEVI-at-44th-Annual-Fall-Clinical-Dermatology-Conference.pdf\">WINLEVI poster presentations at 2024 Fall Clinical Dermatology Conference, <\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/07\/Sunpharma-LEQSELVI-Approval-Scenario-Press-Release.pdf\">U.S. FDA Approves LEQSELVI&trade;(deuruxolitinib), and Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata<\/a><\/td><td class=\"column-2\">July 26, 2024<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-Completes-Taro-Merger.pdf\">Sun Pharma Completes Taro Merger, <\/a><\/td><td class=\"column-2\">June 24, 2024<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-presented-GL0034-phase-1-result-at-the-84th-ADA.pdf\">Sun Pharma&rsquo;s GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions, <\/a><\/td><td class=\"column-2\">June 22, 2024<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Results-of-the-Phase-III-PIVOTAL-trial-of-Nidlegy-in-melanoma-to-be-presented-at-ASCO-2024.pdf\">Press Release Results of the Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024<\/a><\/td><td class=\"column-2\">May 31, 2024<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Taro-Shareholders-Approve-Merger-with-Sun-Pharma.pdf\">Taro Shareholders Approve Merger with Sun Pharma<\/a><\/td><td class=\"column-2\">May 23, 2024<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/01\/1-17-24-Sun-Taro-Joint-Press-Release-Final-for-Release-with-BoA-changes.pdf\">Taro Announces Merger Agreement with Sun Pharma,<\/a><\/td><td class=\"column-2\">January 18, 2024<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-14-no-3 from cache -->\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-179555384\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-179555384\" data-tab-index=\"4\" style=\"--n-tabs-title-order: 4;\" class=\" elementor-element elementor-element-c686f68 e-con-full e-flex e-con e-child\" data-id=\"c686f68\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b442f66 elementor-widget elementor-widget-html\" data-id=\"b442f66\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t\n<table id=\"tablepress-14-no-4\" class=\"tablepress tablepress-id-14\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Press Releases<\/th><th class=\"column-2\">Date<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-LEQSELVI-at-2024-Fall-Clinical-Dermatology-Conference.pdf\">Sun Pharma Presents LEQSELVI at the 2024 Fall Clinical Dermatology Conference,<\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-WINLEVI-at-44th-Annual-Fall-Clinical-Dermatology-Conference.pdf\">WINLEVI poster presentations at 2024 Fall Clinical Dermatology Conference, <\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/07\/Sunpharma-LEQSELVI-Approval-Scenario-Press-Release.pdf\">U.S. FDA Approves LEQSELVI&trade;(deuruxolitinib), and Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata<\/a><\/td><td class=\"column-2\">July 26, 2024<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-Completes-Taro-Merger.pdf\">Sun Pharma Completes Taro Merger, <\/a><\/td><td class=\"column-2\">June 24, 2024<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-presented-GL0034-phase-1-result-at-the-84th-ADA.pdf\">Sun Pharma&rsquo;s GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions, <\/a><\/td><td class=\"column-2\">June 22, 2024<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Results-of-the-Phase-III-PIVOTAL-trial-of-Nidlegy-in-melanoma-to-be-presented-at-ASCO-2024.pdf\">Press Release Results of the Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024<\/a><\/td><td class=\"column-2\">May 31, 2024<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Taro-Shareholders-Approve-Merger-with-Sun-Pharma.pdf\">Taro Shareholders Approve Merger with Sun Pharma<\/a><\/td><td class=\"column-2\">May 23, 2024<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/01\/1-17-24-Sun-Taro-Joint-Press-Release-Final-for-Release-with-BoA-changes.pdf\">Taro Announces Merger Agreement with Sun Pharma,<\/a><\/td><td class=\"column-2\">January 18, 2024<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-14-no-4 from cache -->\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-179555385\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-179555385\" data-tab-index=\"5\" style=\"--n-tabs-title-order: 5;\" class=\" elementor-element elementor-element-33e78b3 e-con-full e-flex e-con e-child\" data-id=\"33e78b3\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8c5e71c elementor-widget elementor-widget-html\" data-id=\"8c5e71c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t\n<table id=\"tablepress-14-no-5\" class=\"tablepress tablepress-id-14\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Press Releases<\/th><th class=\"column-2\">Date<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-LEQSELVI-at-2024-Fall-Clinical-Dermatology-Conference.pdf\">Sun Pharma Presents LEQSELVI at the 2024 Fall Clinical Dermatology Conference,<\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-WINLEVI-at-44th-Annual-Fall-Clinical-Dermatology-Conference.pdf\">WINLEVI poster presentations at 2024 Fall Clinical Dermatology Conference, <\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/07\/Sunpharma-LEQSELVI-Approval-Scenario-Press-Release.pdf\">U.S. FDA Approves LEQSELVI&trade;(deuruxolitinib), and Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata<\/a><\/td><td class=\"column-2\">July 26, 2024<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-Completes-Taro-Merger.pdf\">Sun Pharma Completes Taro Merger, <\/a><\/td><td class=\"column-2\">June 24, 2024<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-presented-GL0034-phase-1-result-at-the-84th-ADA.pdf\">Sun Pharma&rsquo;s GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions, <\/a><\/td><td class=\"column-2\">June 22, 2024<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Results-of-the-Phase-III-PIVOTAL-trial-of-Nidlegy-in-melanoma-to-be-presented-at-ASCO-2024.pdf\">Press Release Results of the Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024<\/a><\/td><td class=\"column-2\">May 31, 2024<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Taro-Shareholders-Approve-Merger-with-Sun-Pharma.pdf\">Taro Shareholders Approve Merger with Sun Pharma<\/a><\/td><td class=\"column-2\">May 23, 2024<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/01\/1-17-24-Sun-Taro-Joint-Press-Release-Final-for-Release-with-BoA-changes.pdf\">Taro Announces Merger Agreement with Sun Pharma,<\/a><\/td><td class=\"column-2\">January 18, 2024<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-14-no-5 from cache -->\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-179555386\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-179555386\" data-tab-index=\"6\" style=\"--n-tabs-title-order: 6;\" class=\" elementor-element elementor-element-93d29f4 e-con-full e-flex e-con e-child\" data-id=\"93d29f4\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0f41637 elementor-widget elementor-widget-html\" data-id=\"0f41637\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t\n<table id=\"tablepress-14-no-6\" class=\"tablepress tablepress-id-14\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Press Releases<\/th><th class=\"column-2\">Date<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-LEQSELVI-at-2024-Fall-Clinical-Dermatology-Conference.pdf\">Sun Pharma Presents LEQSELVI at the 2024 Fall Clinical Dermatology Conference,<\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-WINLEVI-at-44th-Annual-Fall-Clinical-Dermatology-Conference.pdf\">WINLEVI poster presentations at 2024 Fall Clinical Dermatology Conference, <\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/07\/Sunpharma-LEQSELVI-Approval-Scenario-Press-Release.pdf\">U.S. FDA Approves LEQSELVI&trade;(deuruxolitinib), and Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata<\/a><\/td><td class=\"column-2\">July 26, 2024<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-Completes-Taro-Merger.pdf\">Sun Pharma Completes Taro Merger, <\/a><\/td><td class=\"column-2\">June 24, 2024<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-presented-GL0034-phase-1-result-at-the-84th-ADA.pdf\">Sun Pharma&rsquo;s GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions, <\/a><\/td><td class=\"column-2\">June 22, 2024<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Results-of-the-Phase-III-PIVOTAL-trial-of-Nidlegy-in-melanoma-to-be-presented-at-ASCO-2024.pdf\">Press Release Results of the Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024<\/a><\/td><td class=\"column-2\">May 31, 2024<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Taro-Shareholders-Approve-Merger-with-Sun-Pharma.pdf\">Taro Shareholders Approve Merger with Sun Pharma<\/a><\/td><td class=\"column-2\">May 23, 2024<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/01\/1-17-24-Sun-Taro-Joint-Press-Release-Final-for-Release-with-BoA-changes.pdf\">Taro Announces Merger Agreement with Sun Pharma,<\/a><\/td><td class=\"column-2\">January 18, 2024<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-14-no-6 from cache -->\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-179555387\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-179555387\" data-tab-index=\"7\" style=\"--n-tabs-title-order: 7;\" class=\" elementor-element elementor-element-f1c71ae e-con-full e-flex e-con e-child\" data-id=\"f1c71ae\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-62331bc elementor-widget elementor-widget-html\" data-id=\"62331bc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t\n<table id=\"tablepress-14-no-7\" class=\"tablepress tablepress-id-14\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Press Releases<\/th><th class=\"column-2\">Date<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-LEQSELVI-at-2024-Fall-Clinical-Dermatology-Conference.pdf\">Sun Pharma Presents LEQSELVI at the 2024 Fall Clinical Dermatology Conference,<\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/10\/Press-Release-WINLEVI-at-44th-Annual-Fall-Clinical-Dermatology-Conference.pdf\">WINLEVI poster presentations at 2024 Fall Clinical Dermatology Conference, <\/a><\/td><td class=\"column-2\">October 25, 2024<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/07\/Sunpharma-LEQSELVI-Approval-Scenario-Press-Release.pdf\">U.S. FDA Approves LEQSELVI&trade;(deuruxolitinib), and Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata<\/a><\/td><td class=\"column-2\">July 26, 2024<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-Completes-Taro-Merger.pdf\">Sun Pharma Completes Taro Merger, <\/a><\/td><td class=\"column-2\">June 24, 2024<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/06\/Press-Release-Sun-Pharma-presented-GL0034-phase-1-result-at-the-84th-ADA.pdf\">Sun Pharma&rsquo;s GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions, <\/a><\/td><td class=\"column-2\">June 22, 2024<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Results-of-the-Phase-III-PIVOTAL-trial-of-Nidlegy-in-melanoma-to-be-presented-at-ASCO-2024.pdf\">Press Release Results of the Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024<\/a><\/td><td class=\"column-2\">May 31, 2024<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/05\/Press-Release-Taro-Shareholders-Approve-Merger-with-Sun-Pharma.pdf\">Taro Shareholders Approve Merger with Sun Pharma<\/a><\/td><td class=\"column-2\">May 23, 2024<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\"><a href=\"https:\/\/sunpharma.com\/wp-content\/uploads\/2024\/01\/1-17-24-Sun-Taro-Joint-Press-Release-Final-for-Release-with-BoA-changes.pdf\">Taro Announces Merger Agreement with Sun Pharma,<\/a><\/td><td class=\"column-2\">January 18, 2024<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-14-no-7 from cache -->\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Media Press Releases 2025 2024 2023 2022 2021 2020 2019<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-5645","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Media - Sun Pharma USA<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Media - Sun Pharma USA\" \/>\n<meta property=\"og:description\" content=\"Media Press Releases 2025 2024 2023 2022 2021 2020 2019\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.sunpharma.com\/usa\/media\/\" \/>\n<meta property=\"og:site_name\" content=\"Sun Pharma USA\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-07T18:58:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"712\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dev.sunpharma.com\/usa\/media\/\",\"url\":\"https:\/\/dev.sunpharma.com\/usa\/media\/\",\"name\":\"Media - Sun Pharma USA\",\"isPartOf\":{\"@id\":\"https:\/\/dev.sunpharma.com\/usa\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/dev.sunpharma.com\/usa\/media\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/dev.sunpharma.com\/usa\/media\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero.png\",\"datePublished\":\"2025-09-07T18:11:47+00:00\",\"dateModified\":\"2025-09-07T18:58:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/dev.sunpharma.com\/usa\/media\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dev.sunpharma.com\/usa\/media\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dev.sunpharma.com\/usa\/media\/#primaryimage\",\"url\":\"https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero.png\",\"contentUrl\":\"https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero.png\",\"width\":1440,\"height\":712},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dev.sunpharma.com\/usa\/media\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/dev.sunpharma.com\/usa\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Media\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dev.sunpharma.com\/usa\/#website\",\"url\":\"https:\/\/dev.sunpharma.com\/usa\/\",\"name\":\"Sun Pharma USA\",\"description\":\"Just another sunpharma.stagingservice.net Sites site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dev.sunpharma.com\/usa\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Media - Sun Pharma USA","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Media - Sun Pharma USA","og_description":"Media Press Releases 2025 2024 2023 2022 2021 2020 2019","og_url":"https:\/\/dev.sunpharma.com\/usa\/media\/","og_site_name":"Sun Pharma USA","article_modified_time":"2025-09-07T18:58:06+00:00","og_image":[{"width":1440,"height":712,"url":"https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.sunpharma.com\/usa\/media\/","url":"https:\/\/dev.sunpharma.com\/usa\/media\/","name":"Media - Sun Pharma USA","isPartOf":{"@id":"https:\/\/dev.sunpharma.com\/usa\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dev.sunpharma.com\/usa\/media\/#primaryimage"},"image":{"@id":"https:\/\/dev.sunpharma.com\/usa\/media\/#primaryimage"},"thumbnailUrl":"https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero.png","datePublished":"2025-09-07T18:11:47+00:00","dateModified":"2025-09-07T18:58:06+00:00","breadcrumb":{"@id":"https:\/\/dev.sunpharma.com\/usa\/media\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.sunpharma.com\/usa\/media\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dev.sunpharma.com\/usa\/media\/#primaryimage","url":"https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero.png","contentUrl":"https:\/\/dev.sunpharma.com\/usa\/wp-content\/uploads\/sites\/2\/2025\/09\/media_hero.png","width":1440,"height":712},{"@type":"BreadcrumbList","@id":"https:\/\/dev.sunpharma.com\/usa\/media\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.sunpharma.com\/usa\/"},{"@type":"ListItem","position":2,"name":"Media"}]},{"@type":"WebSite","@id":"https:\/\/dev.sunpharma.com\/usa\/#website","url":"https:\/\/dev.sunpharma.com\/usa\/","name":"Sun Pharma USA","description":"Just another sunpharma.stagingservice.net Sites site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.sunpharma.com\/usa\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/dev.sunpharma.com\/usa\/wp-json\/wp\/v2\/pages\/5645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.sunpharma.com\/usa\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dev.sunpharma.com\/usa\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/usa\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/usa\/wp-json\/wp\/v2\/comments?post=5645"}],"version-history":[{"count":33,"href":"https:\/\/dev.sunpharma.com\/usa\/wp-json\/wp\/v2\/pages\/5645\/revisions"}],"predecessor-version":[{"id":5722,"href":"https:\/\/dev.sunpharma.com\/usa\/wp-json\/wp\/v2\/pages\/5645\/revisions\/5722"}],"wp:attachment":[{"href":"https:\/\/dev.sunpharma.com\/usa\/wp-json\/wp\/v2\/media?parent=5645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}